Dalibra (adalimumab biosimilar) / Biocad  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dalibra (adalimumab biosimilar) / Biocad
CALYPSO, NCT02762955: Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Completed
3
344
RoW
BCD-057, adalimumab, Humira®
Biocad
Psoriasis
12/17
10/18

Download Options